Lower riskDrug recall · FDA · Published April 24, 2024
SomerSET Therapeutics Haloperidol Injection Recall: Trace Water Risk
SomerSET Therapeutics recalls Haloperidol decanoate injection 50mg/mL vials due to potential trace water contamination. This may cause adverse reactions. Check your vial lot numbers for affected batches.
“SomerSET Therapeutics Haloperidol Injection Recall: Trace Water Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32710-somerset-therapeutics-haloperidol-injection-recall-trace-water-risk. Based on FDA recall #D-0506-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0506-2024%22&limit=1).
The FDA announced on April 24, 2024, that Somerset Therapeutics LLC is recalling Haloperidol decanoate Injection due to the presence of a foreign substance. The agency stated the oil-based product may contain trace amounts of water for injection.
How to tell if you have it
Brand: SomerSET Therapeutics
Product: Haloperidol decanoate Injection 50mg/mL
NDC 70069-381-01 (1 mL Single-Dose Vials)
NDC 70069-381-10 (10 1mL Single-Dose Vials)
Lot #: A230412A, Exp. Date 07/2025
Lot #: A230412B, Exp. Date 07/2025
The hazard
According to the FDA, this oil-based product may contain trace amounts of water for injection (WFI). The recall is classified as Class II.
Context
GovInfoNow's records show Somerset Therapeutics LLC has issued four other recalls since June 4, 2020. Other recent recalls include a Dexamethasone Injection recall on February 4, 2026, and a Cisatracurium Besylate Injection recall on November 26, 2025. Similar recent recalls of similar products include an Omnipaque Injection recall on March 24, 2026, and Multrys IV injection and Papaverine HCl Injection recalls on July 24, 2026.
How to tell if you have this one
Check for vials labeled 'Haloperidol decanoate Injection 50mg/mL' with lot numbers A230412A (expiring 07/2025) or A230412B (expiring 07/2025).
Brand
SomerSET Therapeutics
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Lot Numbers
Identify affected vials by lot numbers A230412A or A230412B with expiration dates of 07/2025.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 35 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0506-2024 (April 24, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0506-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.